AAD's Dialogues in Dermatology podkast

Bonus: Treatment Decision in Oral vs Injectable Systemic Therapies in Psoriasis (Sponsored by Johnson & Johnson)

0:00
NaN:NaN:NaN
Do tyłu o 15 sekund
Do przodu o 15 sekund
Joel Gelfand, MD, MSCE, FAAD interviewed by Sanna Ronkainen, MD, FAAD

Więcej odcinków z kanału "AAD's Dialogues in Dermatology"